Back to Search Start Over

Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update.

Authors :
Pérez CA
Cuascut FX
Hutton GJ
Source :
Neurologic clinics [Neurol Clin] 2023 Feb; Vol. 41 (1), pp. 87-106. Date of Electronic Publication: 2022 Oct 31.
Publication Year :
2023

Abstract

Multiple sclerosis (MS) is the most prevalent nontraumatic disabling neurologic condition among young adults worldwide. The diagnosis and management of MS is complex. The goal of this review is to provide an updated and practical approach to the diagnosis and treatment approaches in MS, emphasizing current understanding of immunopathogenesis, recent advances, and future directions, for both MS and non-MS clinicians.<br />Competing Interests: Disclosure C.A. Pérez received postgraduate fellowship support from Genentech and has participated in advisory boards for Sanofi. F.X. Cuascut received research funding from Genentech and Biogen and has participated in advisory boards for Genentech, Biogen, Horizon, and Pharma Novartis and Horizon. G.J. Hutton received research funding from Biogen, Hoffman-La Roche, Sanofi, MedImmune, and Novartis and has participated in advisory boards for Novartis and Horizon.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1557-9875
Volume :
41
Issue :
1
Database :
MEDLINE
Journal :
Neurologic clinics
Publication Type :
Academic Journal
Accession number :
36400561
Full Text :
https://doi.org/10.1016/j.ncl.2022.05.004